双腔起搏器市场：现况分析与预测（2023-2030）

Dual Chamber Pacemakers Market: Current Analysis and Forecast (2023-2030)

出版日期: 2023年12月30日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 152 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

双腔起搏器是一种特殊的心臟装置，其导线插入心臟的心房和心室。透过协调心室和心房之间的电讯号，它可以调节心律并提高其有效性。透过同步心房和心室的功能，这些设备旨在重建心臟的自然节律，并在心臟的电气系统需要帮助时提供支持。其他几个因素正在推动双腔起搏器的发展，包括遗传疾病和不健康生活方式的增加。例如，根据BMC Public Health 的数据，2023 年7 月，不健康生活方式的盛行率分别为86.4% 的饮食、14.5% 的酒精、6.0% 的烟草、72.2% 的体力活动、42.3% 的萤幕时间和63.9% 的睡眠时间。

由于全球烟酒流行率不断上升，双腔起搏器市场预计将稳定成长 4.5% 左右。根据 2021 年全国药物使用与健康调查 (NSDUH)，2020 年有 2,950 万名 12 岁及以上的人患有酒精使用障碍 (AUD)。在预测期内，有几个因素正在推动市场成长，包括心臟病发病率的急剧增加、对喉癌的认识不断提高、吸烟人口的增加、酗酒文化的兴起以及对心臟病学的投资增加。我们正在推动。除此之外，透过双腔起搏器提高治疗效率可以加快治疗过程并提高精确度，这也稳步推动了双腔起搏器市场的发展。

依产品类型分为植入式心律调节器和体外心律调节器。由于心律调节器植入数量的增加，2022年植入式心律调节器将占据全球双腔心律调节器市场的最大份额。例如，根据西班牙心臟学会的数据，2021年起搏器植入数量较2020年增加了12.8%，较2018-2019年的平均值增加了3%。植入式心律调节器透过手术植入胸部或腹部，并直接连接到心臟，以持续监测和调整心律。它专为长期使用而设计，并提供持续的支援。由于肥胖率上升、人口老化以及吸烟、酗酒和不健康生活习惯等生活方式相关疾病患者数量的增加，该领域正在主导市场。心臟病家族史也是该细分市场的驱动因素。因此，在癌症类型中，植入式心律调节器领域将在2022年占据很大的市场。

依应用，市场分为心律不整、心搏过缓等。由于人们久坐的生活方式的盛行，预计在预测期内心动过缓部分将占据很大的市场份额。心搏过缓是心律不整的一种，但并非所有心律不整都涉及心率降低。有些心律不整可能会导致您的心臟跳动过快或不规则，但不一定会减慢心跳速度。该领域是由技术进步所驱动的。例如，根据《美国心臟病学杂誌》报道，2020 年 9 月，全球每 600 人中就有 1 人患有心搏过缓。因此，在所有技术中，心搏过缓类别预计在预测期内复合年增长率最高。

为了更了解双腔起搏器的市场介绍，将市场分为北美（美国、加拿大等北美地区）、欧洲（德国、英国、法国、西班牙、义大利等）欧洲地区）和亚太地区（根据世界其他地区（中国、日本、印度、亚太其他地区）和世界其他地区的全球影响力进行分析。在目前的2022年情境中，北美因烟雾污染加剧、酒精消费增加以及开发有效双腔起搏器的投资增加而占据市场主导地位。例如，根据国家药物滥用统计中心的数据，在约翰霍普金斯大学-马里兰大学巴尔的摩分校的一项调查中，60.1% 的参与者表示，自2020 年3 月1 日以来，他们增加了饮酒量。政府机构已启动心臟病意识计划，为患者提供有效的治疗。因此，按地区划分，北美将在 2022 年占据较大市场份额。

Double-chamber pacemakers are specialized cardiac devices employing leads inserted into both the atrium and ventricle of the heart. They work by coordinating electrical signals between these chambers, aiding in the regulation of heart rhythm and enhancing its effectiveness. By synchronizing atrial and ventricular functions, these devices aim to replicate the natural rhythm of the heart, providing support when the heart's electrical system requires assistance. Several other factors, such as rising genetic disorders and unhealthy lifestyles are leading drivers of dual-chamber pacemakers globally. For instance, according to the BMC Public Health, in July 2023, the prevalence of unhealthy lifestyles was 86.4% for diet, 14.5% for alcohol, 6.0% for tobacco, 72.2% for physical activity, 42.3% for screen time, and 63.9% for sleep duration.

The Dual Chamber Pacemakers Market is expected to grow at a steady rate of around 4.5% owing to the increased prevalence of alcohol and tobacco globally. According to the 2021 National Survey on Drug Use and Health (NSDUH), 29.5 million people ages 12 and older had Alcohol Use Disorder (AUD) in the year 2020. Several factors, including a surge in the incidence of cardiac disorders, increasing awareness regarding throat cancer, increasing smoking population, rising alcoholism culture, and increased investments in cardiology departments are driving the growth of the market during the forecast period. Apart from this, accelerated treatment efficiency with dual-chamber pacemakers has resulted in faster treatment procedures and better accuracy which is also driving this market of dual-chamber pacemakers at a steady rate.

Based on product type, the market is segmented into implantable pacemakers and external pacemakers. The implantable pacemakers segment held the maximum share in the global market of dual-chamber pacemakers in 2022 owing to the rising number of pacemaker implants performed. For instance, according to the Spanish Society of Cardiology in 2021, there was a 12.8% increase in pacemaker implants compared with 2020 and a 3% increase compared with the average for 2018 to 2019. Implantable pacemakers are surgically implanted into the chest or abdomen, directly connected to the heart, and continuously monitor and regulate the heart's rhythm. They are designed for long-term use and offer ongoing support. This segment dominated the market because of the rising cases of obesity, increasing geriatric population, and increased prevalence of ill lifestyles including smoking, alcoholism, and unhealthy lifestyles among people. A family history of heart disease is also a propelling factor for this segment. Thus, amongst cancer types, the implantable pacemakers segment held a significant share of the market in 2022.

Based on application, the market is categorized into arrhythmias, bradycardia, and others. The bradycardia segment is expected to hold a significant share of the market in the forecast period owing to the prevalent sedentary lifestyle of people. Bradycardia can be a type of arrhythmia, but not all arrhythmias involve a slow heart rate. Some arrhythmias can cause the heart to beat too fast or irregularly without necessarily slowing it down. This segment is propelled by rising technological advancements. For instance, the incidence of bradycardia was reported to be approximately 1 in 600 individuals worldwide in September 2020 according to the American Journal of Cardiology. Thus, amongst technology, the bradycardia category is expected to witness a higher CAGR during the forecast period.

For a better understanding of the market adoption of dual chamber pacemakers, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the increasing smoke pollution, increasing alcohol consumption, and rising number of investments in developing effective dual chamber pacemakers. For example, according to the National Center for Drug Abuse Statistics, in a Johns Hopkins-University of Maryland-Baltimore survey, 60.1% of participants reported drinking more alcohol after March 1, 2020. Government organizations are initiating cardiac disorder awareness programs to provide efficient care to patients. Thus, amongst regions, North America held a significant share of the market in 2022.

Some of the major players operating in the market include: Abbott; Biotronik; Boston Scientific Corporation; Lepu Medical Application (Beijing)Co., Ltd.; LivaNova PLC; MEDICO S.R.L.; Medtronic; Oscor Inc.; OSYPKA MEDICAL; MicroPort Scientific Corporation.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Dual Chamber Pacemakers Market
2.2. Research Methodology of the Dual Chamber Pacemakers Market
2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE DUAL CHAMBER PACEMAKERS MARKET

6 DUAL CHAMBER PACEMAKERS MARKET REVENUE (USD BN), 2020-2030F

7 MARKET INSIGHTS BY PRODUCT TYPE

7.1. Implantable pacemakers
7.2. External pacemakers

8 MARKET INSIGHTS BY APPLICATION

8.1. Arrhythmias
8.2. Bradycardia
8.3. Others

9 MARKET INSIGHTS BY REGION

9.1. North America
- 9.1.1. U.S.
- 9.1.2. Canada
- 9.1.3. Rest of North America
9.2. Europe
- 9.2.1. Germany
- 9.2.2. U.K.
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Rest of Asia-Pacific
9.4. Rest of World